Cargando…

Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk

OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese mid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfante, Ivan Luiz Padilha, Chacon-Mikahil, Mara Patricia Traina, Brunelli, Diego Trevisan, Gáspari, Arthur Fernandes, Duft, Renata Garbellini, Oliveira, Alexandre Gabarra, Araujo, Tiago Gomes, Saad, Mario Jose Abdalla, Cavaglieri, Cláudia Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522056/
https://www.ncbi.nlm.nih.gov/pubmed/29412381
http://dx.doi.org/10.1590/2359-3997000000305
_version_ 1785110275187277824
author Bonfante, Ivan Luiz Padilha
Chacon-Mikahil, Mara Patricia Traina
Brunelli, Diego Trevisan
Gáspari, Arthur Fernandes
Duft, Renata Garbellini
Oliveira, Alexandre Gabarra
Araujo, Tiago Gomes
Saad, Mario Jose Abdalla
Cavaglieri, Cláudia Regina
author_facet Bonfante, Ivan Luiz Padilha
Chacon-Mikahil, Mara Patricia Traina
Brunelli, Diego Trevisan
Gáspari, Arthur Fernandes
Duft, Renata Garbellini
Oliveira, Alexandre Gabarra
Araujo, Tiago Gomes
Saad, Mario Jose Abdalla
Cavaglieri, Cláudia Regina
author_sort Bonfante, Ivan Luiz Padilha
collection PubMed
description OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese middle-aged men, and also to correlate all variables analyzed with FNDC5/irisin. SUBJECTS AND METHODS: On the basis of a cluster study, middle-aged obese men (IMC: 31.01 ± 1.64 kg/m(2)) were divided into groups of higher and smaller levels of FNDC5/irisin. The levels of leptin, resistin, adiponectin, tumor necrosis factor alpha (TNFα), interleukin 6 and 10 (IL6, IL10), lipopolysaccharide (LPS), glucose, insulin, glycated hemoglobin, insulin resistance and sensibility, lipid profile, risk of T2DM development, body composition, rest energy expenditure, caloric/macronutrient intake and physical fitness were measured. RESULTS: The higher FNDC5/ irisin group presented improved insulin sensibility (homeostasis model assessment - sensibility (HOMA-S) (p = 0.01) and QUICKI index (p < 0.01)), insulin (p = 0.02) and triglyceride levels (p = 0.01), lower insulin resistance (homeostasis model assessment - insulin resistance (HOMA-IR) (p = 0.01), triglycerides/glucose (TYG index) (p = 0.02), neck circumference (p = 0.02), risk of T2DM development (p = 0.02), tendency to decrease serum resistin (p = 0.08) and significant lower LPS levels (p = 0.02). Inverse correlations between FNDC5/irisin and body weight (r −0.46, p = 0.04), neck circumference (r −0.51, p = 0.02), free fat mass (r −0.49, p = 0.02), triglycerides (r −0.43, p = 0.05) and risk of developing T2DM (r −0.61, p = 0.04) were observed. CONCLUSIONS: These results suggest that higher FNDC5/irisin levels in obese middle-aged men are related to a better metabolic profile and lower risk of T2DM development and serum LPS, a potential inducer of insulin resistance.
format Online
Article
Text
id pubmed-10522056
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Endocrinologia e Metabologia
record_format MEDLINE/PubMed
spelling pubmed-105220562023-09-27 Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk Bonfante, Ivan Luiz Padilha Chacon-Mikahil, Mara Patricia Traina Brunelli, Diego Trevisan Gáspari, Arthur Fernandes Duft, Renata Garbellini Oliveira, Alexandre Gabarra Araujo, Tiago Gomes Saad, Mario Jose Abdalla Cavaglieri, Cláudia Regina Arch Endocrinol Metab Original Article OBJECTIVE: Thus, the aim of this study was to compare if higher or smaller fibronectin type 3 domain-containing protein 5 (FNDC5)/irisin levels are associated with inflammatory and metabolic markers, caloric/macronutrient intake, physical fitness and type 2 diabetes mellitus (T2DM) risk in obese middle-aged men, and also to correlate all variables analyzed with FNDC5/irisin. SUBJECTS AND METHODS: On the basis of a cluster study, middle-aged obese men (IMC: 31.01 ± 1.64 kg/m(2)) were divided into groups of higher and smaller levels of FNDC5/irisin. The levels of leptin, resistin, adiponectin, tumor necrosis factor alpha (TNFα), interleukin 6 and 10 (IL6, IL10), lipopolysaccharide (LPS), glucose, insulin, glycated hemoglobin, insulin resistance and sensibility, lipid profile, risk of T2DM development, body composition, rest energy expenditure, caloric/macronutrient intake and physical fitness were measured. RESULTS: The higher FNDC5/ irisin group presented improved insulin sensibility (homeostasis model assessment - sensibility (HOMA-S) (p = 0.01) and QUICKI index (p < 0.01)), insulin (p = 0.02) and triglyceride levels (p = 0.01), lower insulin resistance (homeostasis model assessment - insulin resistance (HOMA-IR) (p = 0.01), triglycerides/glucose (TYG index) (p = 0.02), neck circumference (p = 0.02), risk of T2DM development (p = 0.02), tendency to decrease serum resistin (p = 0.08) and significant lower LPS levels (p = 0.02). Inverse correlations between FNDC5/irisin and body weight (r −0.46, p = 0.04), neck circumference (r −0.51, p = 0.02), free fat mass (r −0.49, p = 0.02), triglycerides (r −0.43, p = 0.05) and risk of developing T2DM (r −0.61, p = 0.04) were observed. CONCLUSIONS: These results suggest that higher FNDC5/irisin levels in obese middle-aged men are related to a better metabolic profile and lower risk of T2DM development and serum LPS, a potential inducer of insulin resistance. Sociedade Brasileira de Endocrinologia e Metabologia 2017-12-01 /pmc/articles/PMC10522056/ /pubmed/29412381 http://dx.doi.org/10.1590/2359-3997000000305 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bonfante, Ivan Luiz Padilha
Chacon-Mikahil, Mara Patricia Traina
Brunelli, Diego Trevisan
Gáspari, Arthur Fernandes
Duft, Renata Garbellini
Oliveira, Alexandre Gabarra
Araujo, Tiago Gomes
Saad, Mario Jose Abdalla
Cavaglieri, Cláudia Regina
Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title_full Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title_fullStr Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title_full_unstemmed Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title_short Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
title_sort obese with higher fndc5/irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522056/
https://www.ncbi.nlm.nih.gov/pubmed/29412381
http://dx.doi.org/10.1590/2359-3997000000305
work_keys_str_mv AT bonfanteivanluizpadilha obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT chaconmikahilmarapatriciatraina obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT brunellidiegotrevisan obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT gaspariarthurfernandes obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT duftrenatagarbellini obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT oliveiraalexandregabarra obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT araujotiagogomes obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT saadmariojoseabdalla obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk
AT cavagliericlaudiaregina obesewithhigherfndc5irisinlevelshaveabettermetabolicprofilelowerlipopolysaccharidelevelsandtype2diabetesrisk